Literature DB >> 30660869

Evaluation of cellular ingrowth within porcine extracellular matrix scaffolding in congenital heart disease surgery.

Jesse L Cox1, James M Hammel2, Stanley J Radio3.   

Abstract

The search for an ideal material for cardiac tissue repair has led to utilization of porcine small intestinal submucosa extracellular matrix (CorMatrix). Here, we examine the histologic features of CorMatrix and the associated cellular growth at a variety of time intervals. Tissues with CorMatrix from ten patients (4 male, 6 female) with ages ranging from 2 weeks to 2 years, and implant duration ranging from 1 week to 2 years were included in this study. Samples for analysis were collected at autopsy. Surgical repair sites included great vessel repair (n=9), atrial septum defect (n=1), coronary vessels (n=1), as well as aortic (n=1) and mitral valve (n=2) leaflets. In all specimens, CorMatrix was composed of dense laminated regions of collagen, without appreciable elastin staining. In most grafts, especially those implanted for extended periods of time, tissue with luminal CD31 positivity covered the intimal surface of the CorMatrix graft. This tissue (neo-intima) consisted of spindled myofibroblasts (SMA) and small CD31 positive vessels with occasional mononuclear cells in a matrix composed of collagen, glycosaminoglycans, and rarely elastin, after extended periods of implantation. These features were readily identified in patients as early as 1 month after CorMatrix implantation. The matrix comprising the CorMatrix itself remained largely acellular, despite implantation times up to 2 years, with degradation of the graft material. We provide a framework for histologic expectations when evaluating explanted CorMatrix grafts. In this regard, the CorMatrix matrix is likely to remain acellular without significant elastin deposition, whereas the intimal and adventitial surfaces become coated by proliferating cells in a novel matrix of collagen and glycosaminoglycans.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; CorMatrix; Extracellular matrix; Great vessel repair

Mesh:

Substances:

Year:  2018        PMID: 30660869     DOI: 10.1016/j.carpath.2018.12.003

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  4 in total

Review 1.  Bioengineering Human Tissues and the Future of Vascular Replacement.

Authors:  Mehmet H Kural; Yuling Li; Juan Wang; Kaleb M Naegeli; Emmanuelle A Hugentobler; Laura E Niklason
Journal:  Circ Res       Date:  2022-06-23       Impact factor: 23.213

2.  Wharton's Jelly-Mesenchymal Stem Cell-Engineered Conduit for Pulmonary Artery Reconstruction in Growing Piglets.

Authors:  Filippo Rapetto; Dominga Iacobazzi; Srinivas A Narayan; Katie Skeffington; Tasneem Salih; Shahd Mostafa; Valeria V Alvino; Adrian Upex; Paolo Madeddu; Mohamed T Ghorbel; Massimo Caputo
Journal:  JACC Basic Transl Sci       Date:  2022-02-23

3.  Reconstruction of the Neopulmonary Root After Coronary Button Harvest for Arterial Switch Operation Using 2-ply Extracellular Matrix (Tyke): A Post-Implant Histology.

Authors:  Steve Bibevski; Mark Ruzmetov; Elena Ladich; Laura E Mendoza; Frank G Scholl
Journal:  Front Cardiovasc Med       Date:  2020-10-30

4.  Pathological Changes of Adult Mitral Valves after Failed CorMatrix ECM Repair.

Authors:  Baidarbhi Chakraborty; He Wang
Journal:  J Clin Transl Pathol       Date:  2021-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.